Story perspectives

Australia Approves Breakthrough Chlamydia Vaccine for Koalas

9/12/2025

Summary

Story summary

The University of the Sunshine Coast's chlamydia vaccine for koalas has received national approval in Australia, a key conservation achievement.
This single-dose vaccine, developed over ten years, simplifies administration without anesthesia.
Initial production will provide around 500 doses, focusing on at-risk koalas from a population estimated at 224,000 to 524,000.
Trials indicate a 65% reduction in chlamydia-related deaths, addressing a disease impacting up to 70% of some populations.
Experts emphasize the importance of additional conservation efforts to tackle habitat loss and other threats.

1 of 1

Story summary

The University of the Sunshine Coast's chlamydia vaccine for koalas has received national approval in Australia, a key conservation achievement.
This single-dose vaccine, developed over ten years, simplifies administration without anesthesia.
Initial production will provide around 500 doses, focusing on at-risk koalas from a population estimated at 224,000 to 524,000.
Trials indicate a 65% reduction in chlamydia-related deaths, addressing a disease impacting up to 70% of some populations.
Experts emphasize the importance of additional conservation efforts to tackle habitat loss and other threats.